10-Q Filing

BNB PLUS CORP. CIK: 744452 Q3 2023

Filing Information

Form Type	10-Q
Accession Number	`0001410578-23-001688`
Period End Date	20230630
Filing Date	20230810
Fiscal Year	2023
Fiscal Period	Q3
XBRL Instance	apdn-20230630x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 75 Income Statement 85 Cash Flow Statement 61 Stockholders Equity 38

Balance Sheet 75 line items

Line Item	Tag	Value	Unit	Period
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$330.85K	USD	Point-in-time
Allowance on accounts receivable	`AllowanceForDoubtfulAccountsReceivableCurrent`	$75.00K	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$15.22M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$10.76M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 and $330,853 at June 30, 2023 and September 30, 2022, respectively	`AccountsReceivableNetCurrent`	$3.07M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Accounts receivable, net of allowance of $75,000 and $330,853 at June 30, 2023 and September 30, 2022, respectively	`AccountsReceivableNetCurrent`	$682.70K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$276.42K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Inventories	`InventoryNet`	$602.24K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$524.90K	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.06M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$19.94M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$12.24M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	200.00M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.91M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.91M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.17M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$2.22M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$750.00K	USD	Point-in-time
Capitalized transaction costs	`CapitalizedTransactionCostsForAssetPurchaseTransaction`	$275.73K	USD	Point-in-time
Operating right of use asset	`OperatingLeaseRightOfUseAsset`	$1.36M	USD	Point-in-time
Deposits	`DepositsAssetsNoncurrent`	$99.00K	USD	Point-in-time
Total assets	`Assets`	$22.27M	USD	Point-in-time
Total assets	`Assets`	$15.79M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$2.13M	USD	Point-in-time
Accounts payable and accrued liabilities	`AccountsPayableAndAccruedLiabilitiesCurrent`	$3.62M	USD	Point-in-time
Operating lease liability, current	`OperatingLeaseLiabilityCurrent`	$487.43K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$563.56K	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$275.88K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.19M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.89M	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Long term accrued liabilities	`AccountsPayableAndAccruedLiabilitiesNoncurrent`	$31.47K	USD	Point-in-time
Operating lease liability, long term	`OperatingLeaseLiabilityNoncurrent`	$868.08K	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$5.14M	USD	Point-in-time
Warrants classified as a liability	`CommonWarrantLiabilityNoncurrent`	$4.80M	USD	Point-in-time
Total liabilities	`Liabilities`	$9.36M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.60M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30 2023 and September 30, 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, par value $0.001 per share; 10,000,000 shares authorized; -0- shares issued and outstanding as of June 30 2023 and September 30, 2022, respectively	`PreferredStockValue`	-	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of June 30, 2023 and September 30, 2022, 12,908,520 shares issued and outstanding as of June 30, 2023, 2023 and September 30, 2022	`CommonStockValue`	$12.91K	USD	Point-in-time
Common stock, par value $0.001 per share; 200,000,000 shares authorized as of June 30, 2023 and September 30, 2022, 12,908,520 shares issued and outstanding as of June 30, 2023, 2023 and September 30, 2022	`CommonStockValue`	$12.91K	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$305.40M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapitalCommonStock`	$306.09M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-298.85M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-292.50M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$12.91M	USD	Point-in-time
Applied DNA Sciences, Inc. stockholders' equity	`StockholdersEquity`	$7.25M	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-55.36K	USD	Point-in-time
Noncontrolling interest	`MinorityInterest`	$-2.89K	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.19M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.79M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Total equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$15.79M	USD	Point-in-time
Total liabilities and equity	`LiabilitiesAndStockholdersEquity`	$22.27M	USD	Point-in-time

Income Statement 85 line items

Line Item	Tag	Value	Unit	Period
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$12.59M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$14.61M	USD	3 Qtrs
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.92M	USD	1 Quarter
Total revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$4.30M	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$3.26M	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$1.65M	USD	1 Quarter
Total cost of revenues	`CostOfRevenue`	$7.13M	USD	3 Qtrs
Total cost of revenues	`CostOfRevenue`	$9.97M	USD	3 Qtrs
Gross profit	`GrossProfit`	$4.64M	USD	3 Qtrs
Gross profit	`GrossProfit`	$5.45M	USD	3 Qtrs
Gross profit	`GrossProfit`	$1.27M	USD	1 Quarter
Gross profit	`GrossProfit`	$1.04M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$11.34M	USD	3 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.03M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$3.29M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$9.44M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$836.12K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$863.02K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$3.01M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$2.80M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$3.90M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$12.24M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$14.35M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$4.13M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-6.78M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-9.72M	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.86M	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-2.86M	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$26.78K	USD	1 Quarter
Interest income	`InterestIncomeExpenseNet`	$5.81K	USD	3 Qtrs
Interest income	`InterestIncomeExpenseNet`	$34.11K	USD	3 Qtrs
Transaction costs allocated to warrant liabilities	`TransactionCostAllocatedToWarrantLiabilities`	$-391.33K	USD	3 Qtrs
Unrealized (loss) gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-334.70K	USD	3 Qtrs
Unrealized (loss) gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-2.54M	USD	3 Qtrs
Unrealized (loss) gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$278.40K	USD	1 Quarter
Unrealized (loss) gain on change in fair value of warrants classified as a liability	`FairValueAdjustmentOfWarrants`	$-1.76M	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-3.47K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-26.35K	USD	1 Quarter
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$-43.23K	USD	3 Qtrs
Other (expense) income, net	`OtherNonoperatingIncomeExpense`	$6.40K	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-7.61M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-3.11M	USD	1 Quarter
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-6.41M	USD	3 Qtrs
Loss before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-1.12M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$551.18K	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-6.41M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-4.72M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-3.84M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.12M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-1.76M	USD	1 Quarter
NET LOSS	`ProfitLoss`	$-7.61M	USD	3 Qtrs
NET LOSS	`ProfitLoss`	$-3.11M	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-576.00	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-52.47K	USD	3 Qtrs
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-14.43K	USD	1 Quarter
Less: Net loss attributable to noncontrolling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-833.00	USD	3 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-3.10M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-1.12M	USD	1 Quarter
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-7.60M	USD	3 Qtrs
NET LOSS attributable to Applied DNA Sciences, Inc.	`NetIncomeLoss`	$-6.35M	USD	3 Qtrs
Deemed dividend related to warrant modification	`DeemedDividendRelatedToWarrantModifications`	$110.11K	USD	3 Qtrs
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.12M	USD	1 Quarter
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-7.71M	USD	3 Qtrs
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.35M	USD	3 Qtrs
NET LOSS attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.10M	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.49	USD	3 Qtrs
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.94	USD	3 Qtrs
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.13	USD	1 Quarter
Net loss per share attributable to common stockholders - basic	`EarningsPerShareBasic`	$-0.24	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.49	USD	3 Qtrs
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.24	USD	1 Quarter
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.94	USD	3 Qtrs
Net loss per share attributable to common stockholders - diluted	`EarningsPerShareDiluted`	$-0.13	USD	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.98M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	3 Qtrs
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	12.91M	shares	1 Quarter
Weighted average shares outstanding - basic	`WeightedAverageNumberOfSharesOutstandingBasic`	8.18M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.18M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	3 Qtrs
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	8.98M	shares	1 Quarter
Weighted average shares outstanding - diluted	`WeightedAverageNumberOfDilutedSharesOutstanding`	12.91M	shares	1 Quarter

Cash Flow Statement 61 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$551.18K	USD	1 Quarter
Net loss	`ProfitLoss`	$-6.41M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net loss	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.12M	USD	1 Quarter
Net loss	`ProfitLoss`	$-1.76M	USD	1 Quarter
Net loss	`ProfitLoss`	$-7.61M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-3.11M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$962.80K	USD	3 Qtrs
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$1.03M	USD	3 Qtrs
Gain on sale of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$6.08K	USD	3 Qtrs
Unrealized gain on change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-334.70K	USD	3 Qtrs
Unrealized gain on change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-2.54M	USD	3 Qtrs
Unrealized gain on change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$278.40K	USD	1 Quarter
Unrealized gain on change in fair value of warrants	`FairValueAdjustmentOfWarrants`	$-1.76M	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$692.39K	USD	3 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$2.25M	USD	3 Qtrs
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$-255.85K	USD	3 Qtrs
Change in provision for bad debts	`ProvisionForDoubtfulAccounts`	$10.00K	USD	3 Qtrs
Write-off of property and equipment	`WriteOffOfPropertyAndEquipment`	$62.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$64.93K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.64M	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-325.82K	USD	3 Qtrs
Inventories	`IncreaseDecreaseInInventories`	$-815.29K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$603.44K	USD	3 Qtrs
Prepaid expenses and other current assets and deposits	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-632.15K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$586.38K	USD	3 Qtrs
Accounts payable and accrued liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-1.63M	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$476.26K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenues`	$-287.67K	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-3.54M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-5.72M	USD	3 Qtrs
Capitalized transaction costs for asset purchase transaction	`CapitalizedTransactionCostsForAssetPurchaseTransactionInvestingActivities`	$137.60K	USD	3 Qtrs
Proceeds from sale of property and equipment	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$45.00K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$78.53K	USD	3 Qtrs
Purchase of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$246.89K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-171.14K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-246.89K	USD	3 Qtrs
Net proceeds from exercise of warrants	`ProceedsFromWarrantExercises`	$75.00	USD	3 Qtrs
Net proceeds from issuance of common stock and warrants	`NetProceedsFromSaleOfCommonStockAndWarrants`	$4.09M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$4.09M	USD	3 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.87M	USD	3 Qtrs
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-3.71M	USD	3 Qtrs
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.51M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$6.55M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$15.22M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$4.68M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$11.51M	USD	Point-in-time
Cash paid during period for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid during period for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Property and equipment acquired, and included in accounts payable	`PropertyPlantAndEquipmentAcquiredAndIncludedInAccountsPayable`	$249.47K	USD	3 Qtrs
Deemed dividend warrant modifications	`DeemedDividendWarrantModifications`	$110.11K	USD	3 Qtrs
Leased assets obtained in exchange for new operating lease liabilities	`RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability`	$1.55M	USD	3 Qtrs
Fair value of warrants issued	`FairValueOfWarrantsIssued`	$3.35M	USD	3 Qtrs
Transaction costs for asset purchase included in accounts payable	`TransactionCostsForAssetPurchaseIncludedInAccountsPayable`	$138.12K	USD	3 Qtrs
Issuance of stock options for payment of accrued bonus	`IssuanceOfStockOptionsIssuedForPaymentOfAccruedBonus`	$300.00K	USD	3 Qtrs

Stockholders Equity 38 line items

Line Item	Tag	Value	Unit	Period
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.19M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Exercise of warrants	`StockIssuedDuringPeriodValueWarrantsExercised`	$74.00	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.70M	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$340.04K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.75K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$258.60K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$272.91K	USD	1 Quarter
Stock based compensation expense	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$272.92K	USD	1 Quarter
Common stock issued in public offering, net of offering costs	`SharesIssuedInPublicOffering`	$-4.09M	USD	1 Quarter
Fair value of warrants issued in connection with public offering	`WarrantsIssuedDuringPeriodValueWarrants`	$-3.35M	USD	1 Quarter
Options issued in settlement of accrued bonus	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$300.00K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$551.18K	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-6.41M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-4.72M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-3.84M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.12M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-1.76M	USD	1 Quarter
Net income (loss)	`ProfitLoss`	$-7.61M	USD	3 Qtrs
Net income (loss)	`ProfitLoss`	$-3.11M	USD	1 Quarter
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.16M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$11.11M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$8.39M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.19M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$6.79M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$9.97M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$12.91M	USD	Point-in-time
Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$7.65M	USD	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time
Balance (in shares)	`CommonStockSharesOutstanding`	12.91M	shares	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.